volume 40, issue 5, Pe140-e143 2012
DOI: 10.1016/j.jcms.2011.07.010
View full text
|
|
Share
Renata Gonçalves Resende, Raissa Gabriela Lopes Teixeira, Fabiana de Oliveira Vasconcelos, Maria Elisa de Souza Silva, Mauro Henrique Guimarães Abreu, Ricardo Santiago Gomez

Abstract: Pigmentation of the oral mucosa can indicate a wide range of lesions or conditions. Some drugs are associated with pigmented lesions of oral cavity. Imatinib mesylate (Gleevec(®)) is a protein inhibitor used in the management of several hematological malignancies associated with dermatological side effects, like hyperpigmentation. We report the case of a 38-year-old male post-HSCT patient who had been using imatinib mesylate for over 5 years and presented with blue pigmentation on the hard palate, the left sid…

expand abstract